Table 1.
Patient population
| Age | Sex | Primary | TMN | Stage | Perineural invasion |
ECS | Lymphovascular spread |
Positive margins |
|---|---|---|---|---|---|---|---|---|
| Untreated | ||||||||
| 68 | M | Oral cavity | T4N2b | 4 | No | No | No | Yes |
| 57 | M | Nasal cavity | T1Nx | 1 | Yes | Unknown | Yes | Yes |
| 55 | M | Oral cavity | T3N2b | 4 | No | No | No | Yes |
| 48 | M | Oral cavity | T4N2b | 4 | No | No | No | No |
| 54 | M | Oral cavity | T4N3 | 4 | No | Yes | No | No |
| 77 | F | Oral cavity | T4Nx | 4 | Yes | Unknown | No | No |
| 1,25(OH)2D3 treated | ||||||||
| 58 | M | Oral cavity | T3N0 | 3 | Yes | No | No | No |
| 61 | M | Oral cavity | T4N0 | 4 | Yes | No | Yes | Yes |
| 44 | F | Oral cavity | T4N0 | 4 | Yes | No | No | No |
| 44 | M | Oral cavity | T1N0 | 1 | No | No | No | No |
| 69 | M | Oral cavity | T4N1 | 4 | Yes | No | No | No |
| 75 | F | Oral cavity | T1N0 | 1 | Yes | No | No | No |
| 72 | M | Oral cavity | T3N2C | 4 | No | No | No | Yes |
| 42 | M | Oral cavity | T4N0 | 4 | Yes | No | Yes | No |
| 58 | M | Oral cavity | T2N0 | 2 | Yes | No | Yes | No |
| 74 | F | Oropharynx | T2N0 | 2 | Yes | No | No | Yes |
| 60 | F | Oropharynx | T2N2 | 4 | No | Yes | Yes | No |
M, male; F, female.